Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vandemeulebroecke

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Biometrical Journal. Biometrische Zeitschrift|October 9, 2018
Multistate modeling and simulation of patient trajectories after allogeneic hematopoietic stem cell transplantation to inform drug developmentDavid A James, Jennifer Ng, Jiawei Wei, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Assessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methodsMarc Vandemeulebroecke, Jürgen Lembcke, Herbert Wiesinger, et al.
Clinical Trials (London, England)|February 5, 2024
New strategies for confirmatory testing of secondary hypotheses on combined data from multiple trialsMarc Vandemeulebroecke, Dieter A Häring, Eva Hua, et al.
Contemporary Clinical Trials|May 24, 2023
A Bayesian approach to clinical trial designs in dermatology with multiple simultaneous treatments per subject and multiple ratersLorenz Uhlmann, Christian Stock, Marc Vandemeulebroecke, et al.
Dermatology and Therapy|December 6, 2021
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe PsoriasisCurdin Conrad, Christine-Elke Ortmann, Marc Vandemeulebroecke, et al.
Pharmaceutical Statistics|September 17, 2013
A practical guide to Bayesian group sequential designsThomas Gsponer, Florian Gerber, Björn Bornkamp, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly SubjectsMarc Vandemeulebroecke, Björn Bornkamp, Tillmann Krahnke, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.
Pharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.
Archives of Orthopaedic and Trauma Surgery|August 2, 2021
Instability and results after non-operative treatment of large anterior glenoid rim fractures: is there a correlation between fragment size or displacement and recurrence?Matthias Königshausen, Simon Pätzholz, Marlon Coulibaly, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Biometrical Journal. Biometrische Zeitschrift|October 9, 2018
Multistate modeling and simulation of patient trajectories after allogeneic hematopoietic stem cell transplantation to inform drug developmentDavid A James, Jennifer Ng, Jiawei Wei, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Assessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methodsMarc Vandemeulebroecke, Jürgen Lembcke, Herbert Wiesinger, et al.
Clinical Trials (London, England)|February 5, 2024
New strategies for confirmatory testing of secondary hypotheses on combined data from multiple trialsMarc Vandemeulebroecke, Dieter A Häring, Eva Hua, et al.
Contemporary Clinical Trials|May 24, 2023
A Bayesian approach to clinical trial designs in dermatology with multiple simultaneous treatments per subject and multiple ratersLorenz Uhlmann, Christian Stock, Marc Vandemeulebroecke, et al.
Dermatology and Therapy|December 6, 2021
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe PsoriasisCurdin Conrad, Christine-Elke Ortmann, Marc Vandemeulebroecke, et al.
Pharmaceutical Statistics|September 17, 2013
A practical guide to Bayesian group sequential designsThomas Gsponer, Florian Gerber, Björn Bornkamp, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly SubjectsMarc Vandemeulebroecke, Björn Bornkamp, Tillmann Krahnke, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.
Pharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.
Archives of Orthopaedic and Trauma Surgery|August 2, 2021
Instability and results after non-operative treatment of large anterior glenoid rim fractures: is there a correlation between fragment size or displacement and recurrence?Matthias Königshausen, Simon Pätzholz, Marlon Coulibaly, et al.
Pageof 4